Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.53 USD | +1.73% | -1.24% | -32.93% |
Financials (USD)
Sales 2024 * | 679M | Sales 2025 * | 791M | Capitalization | 4.47B |
---|---|---|---|---|---|
Net income 2024 * | -184M | Net income 2025 * | -107M | EV / Sales 2024 * | 6.12 x |
Net cash position 2024 * | 319M | Net cash position 2025 * | 363M | EV / Sales 2025 * | 5.2 x |
P/E ratio 2024 * |
-23.5
x | P/E ratio 2025 * |
-41.6
x | Employees | 1,259 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.78% |
Latest transcript on 10x Genomics, Inc.
1 day | +1.73% | ||
1 week | -1.24% | ||
Current month | -19.53% | ||
1 month | -19.62% | ||
3 months | -34.79% | ||
6 months | -9.02% | ||
Current year | -32.93% |
Managers | Title | Age | Since |
---|---|---|---|
Serge Saxonov
FOU | Founder | 47 | 12-07-01 |
Ben Hindson
FOU | Founder | 49 | 12-07-01 |
Justin McAnear
DFI | Director of Finance/CFO | 49 | 18-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Stuelpnagel
CHM | Chairman | 66 | 13-07-31 |
Kim Popovits
BRD | Director/Board Member | 65 | 20-03-25 |
Mathai Mammen
BRD | Director/Board Member | 57 | 17-08-22 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 37.53 | +1.73% | 1,527,814 |
24-03-27 | 36.89 | +1.77% | 1,078,427 |
24-03-26 | 36.25 | -0.17% | 1,329,613 |
24-03-25 | 36.31 | +0.06% | 1,161,384 |
24-03-22 | 36.29 | -4.50% | 1,318,481 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.93% | 4.4B | |
-13.95% | 8.1B | |
-4.01% | 5.13B | |
-0.04% | 4.72B | |
+0.39% | 4.14B | |
+16.88% | 2.82B | |
+3.24% | 2.55B | |
+11.39% | 1.92B | |
+1.28% | 1.65B | |
-2.46% | 1.52B |